Related references
Note: Only part of the references are listed.CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
Xiaojing Yang et al.
PLOS ONE (2009)
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander et al.
BLOOD (2008)
DACT3 is an epigenetic regulator of Wnt/β-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications
Xia Jiang et al.
CANCER CELL (2008)
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C. Hallstrom et al.
CANCER CELL (2008)
Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation
Satoshi Fujii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines
M. Kitagawa et al.
ONCOGENE (2008)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
E2F-at the crossroads of life and death
Shirley Polager et al.
TRENDS IN CELL BIOLOGY (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
Life and death decisions by the E2F transcription factors
Phillip J. Iaquinta et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
An elaborate pathway required for Ras-mediated epigenetic silencing
Claude Gazin et al.
NATURE (2007)
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells
Xiao Dong Zhao et al.
CELL STEM CELL (2007)
c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1
Victoria H. Cowling et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells
Guangjin Pan et al.
CELL STEM CELL (2007)
E2F1 death pathways as targets for cancer therapy
B. M. Puetzer
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity
J Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Epigenetics provides a new generation of oncogenes and tumour-suppressor genes
M Esteller
BRITISH JOURNAL OF CANCER (2006)
Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim
Y Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis
T Hershko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
E2F target genes: unraveling the biology
AP Bracken et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
siRNA-mediated gene silencing: a global genome view
D Semizarov et al.
NUCLEIC ACIDS RESEARCH (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Specificity in the activation and control of transcription factor E2F-dependent apoptosis
TC Hallstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Direct coupling of the cell cycle and cell death machinery by E2F
Z Nahle et al.
NATURE CELL BIOLOGY (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents
L Johnson et al.
CANCER CELL (2002)
Apaf-1 is a transcriptional target for E2F and p53
MC Moroni et al.
NATURE CELL BIOLOGY (2001)
Role of the p53-homologue p73 in EZF1-induced apoptosis
T Stiewe et al.
NATURE GENETICS (2000)
Role for the p53 homologue p73 in E2F-1-induced apoptosis
M Irwin et al.
NATURE (2000)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
Apoptotic and growth-promoting activity of E2F modulated by MDM2
O Loughran et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
